5 Best Pharma Dividend Stocks To Buy

1. Merck & Co., Inc. (NYSE:MRK)

Number of Hedge Fund Holders: 79

Dividend Yield as of October 27: 2.75%

Merck & Co., Inc. (NYSE:MRK) is a New Jersey-based healthcare company that operates through Pharmaceutical and Animal Health segments. The Pharmaceutical segment offers human health pharmaceutical products and vaccines in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes. On October 27, Merck & Co., Inc. (NYSE:MRK) posted market-beating Q3 2022 results and raised the FY22 outlook. It is one of the best dividend stocks to monitor. 

On October 12, Barclays analyst Carter Gould raised the firm’s price target on the shares to $105 from $101 and reiterated an Overweight rating on the shares.

Among the hedge funds tracked by Insider Monkey, Merck & Co., Inc. (NYSE:MRK) was part of 79 public stock portfolios, compared to 84 in the preceding quarter. Ken Fisher’s Fisher Asset Management featured as the leading stakeholder of the company, with 12.12 million shares valued at $1.10 billion. 

Here is what Carillon Tower Advisers specifically said about Merck & Co., Inc. (NYSE:MRK) in its Q2 2022 investor letter:

“Merck & Co., Inc. (NYSE:MRK) reported a strong first quarter and raised its financial guidance for 2022. The company also continues to benefit from the recent rotation into pharmaceuticals, which historically has been a more defensive industry.”

You can also take a look at 15 Biggest Hedge Funds in USA and Top 10 Women Owned Stocks To Buy. 

Follow Insider Monkey on Twitter